Legionella-Like Amebal Pathogens and Their Role in Respiratory Disease
Author Information
Author(s): Adenike Adeleke, M.S., Janet Pruckler, Robert Benson, M.S., Timothy Rowbotham, Ph.D., Mahmoud Halablab, Ph.D., Barry Fields, Ph.D.
Primary Institution: Kings' College, London, UK; Centers for Disease Control and Prevention, Atlanta, Georgia, USA; Public Health Laboratory, Leeds, UK
Hypothesis
Are Legionella-like amebal pathogens (LLAPs) significant causes of respiratory disease?
Conclusion
LLAPs may be an unrecognized cause of respiratory disease, particularly in pneumonia cases of unidentified origin.
Supporting Evidence
- 19% of 500 hospitalized pneumonia patients showed a significant rise in antibodies to LLAPs.
- More than 10 cases of rising titers to LLAP-3 were found in patients with suspected Legionnaires' disease.
- LLAPs were isolated from clinical samples where conventional tests for Legionella were negative.
Takeaway
Some tiny germs called LLAPs might make people sick with pneumonia, but we can't easily find them in tests.
Methodology
The study involved screening sera from pneumonia patients for antibodies to LLAPs and analyzing 16S rRNA gene sequences.
Potential Biases
Cross-reactivity or nonspecific antibody rises may have affected some results.
Limitations
LLAPs cannot be easily cultured or identified using standard laboratory techniques.
Participant Demographics
500 hospitalized patients with pneumonia of unidentified origin.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website